Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Translational Phase II Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer

NCT03829345 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT03829345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03829345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Translational Phase II Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Phase 2
Overall status
Unknown status
Start date
July 2, 2019
Completion date
February 14, 2022
Enrollment
54 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, gastro-oesophageal junction cancer, oesophageal cancer